Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 28

1.

Trends in the diagnosis and clinical features of melanoma in situ (MIS) in US men and women: A prospective, observational study.

Wei EX, Qureshi AA, Han J, Li TY, Cho E, Lin JY, Li WQ.

J Am Acad Dermatol. 2016 Oct;75(4):698-705. doi: 10.1016/j.jaad.2016.05.011. Epub 2016 Jul 16.

PMID:
27436155
2.

Sun exposure and melanoma prognostic factors.

Gandini S, Montella M, Ayala F, Benedetto L, Rossi CR, Vecchiato A, Corradin MT, DE Giorgi V, Queirolo P, Zannetti G, Giudice G, Borroni G, Forcignanò R, Peris K, Tosti G, Testori A, Trevisan G, Spagnolo F, Ascierto PA; CLINICAL NATIONAL MELANOMA REGISTRY GROUP.

Oncol Lett. 2016 Apr;11(4):2706-2714. Epub 2016 Mar 1.

3.

Incidence of cutaneous malignant melanoma by socioeconomic status in Canada: 1992-2006.

Johnson-Obaseki SE, Labajian V, Corsten MJ, McDonald JT.

J Otolaryngol Head Neck Surg. 2015 Dec 2;44:53. doi: 10.1186/s40463-015-0107-1.

4.

An assessment of histological margins and recurrence of melanoma in situ.

Joyce KM, Joyce CW, Jones DM, Donnellan P, Hussey AJ, Regan PJ, Kelly JL.

Plast Reconstr Surg Glob Open. 2015 Mar 6;3(2):e301. doi: 10.1097/GOX.0000000000000272. eCollection 2015 Feb.

5.

Using topical imiquimod for the management of positive in situ margins after melanoma resection.

Pandit AS, Geiger EJ, Ariyan S, Narayan D, Choi JN.

Cancer Med. 2015 Apr;4(4):507-12. doi: 10.1002/cam4.402. Epub 2015 Jan 26.

6.

miR-98 suppresses melanoma metastasis through a negative feedback loop with its target gene IL-6.

Li F, Li XJ, Qiao L, Shi F, Liu W, Li Y, Dang YP, Gu WJ, Wang XG, Liu W.

Exp Mol Med. 2014 Oct 3;46:e116. doi: 10.1038/emm.2014.63.

7.

Melanoma incidence trends and survival in adolescents and young adults in Queensland, Australia.

Iannacone MR, Youlden DR, Baade PD, Aitken JF, Green AC.

Int J Cancer. 2015 Feb 1;136(3):603-9. doi: 10.1002/ijc.28956. Epub 2014 May 17.

8.

Increasing incidence of melanoma among middle-aged adults: an epidemiologic study in Olmsted County, Minnesota.

Lowe GC, Saavedra A, Reed KB, Velazquez AI, Dronca RS, Markovic SN, Lohse CM, Brewer JD.

Mayo Clin Proc. 2014 Jan;89(1):52-9. doi: 10.1016/j.mayocp.2013.09.014.

9.

Melanoma biomolecules: independently identified but functionally intertwined.

Dye DE, Medic S, Ziman M, Coombe DR.

Front Oncol. 2013 Sep 24;3:252. doi: 10.3389/fonc.2013.00252. Review.

10.

Melanoma epidemic: an analysis of six decades of data from the Connecticut Tumor Registry.

Geller AC, Clapp RW, Sober AJ, Gonsalves L, Mueller L, Christiansen CL, Shaikh W, Miller DR.

J Clin Oncol. 2013 Nov 20;31(33):4172-8. doi: 10.1200/JCO.2012.47.3728. Epub 2013 Sep 16.

12.

Melanoma. Shall we move away from the sun and focus more on embryogenesis, body weight and longevity?

Bataille V.

Med Hypotheses. 2013 Nov;81(5):846-50. doi: 10.1016/j.mehy.2013.05.031. Epub 2013 Jun 21. Review.

13.

Comparison of responses of human melanoma cell lines to MEK and BRAF inhibitors.

Stones CJ, Kim JE, Joseph WR, Leung E, Marshall ES, Finlay GJ, Shelling AN, Baguley BC.

Front Genet. 2013 May 8;4:66. doi: 10.3389/fgene.2013.00066. eCollection 2013.

14.

Incidence of childhood and adolescent melanoma in the United States: 1973-2009.

Wong JR, Harris JK, Rodriguez-Galindo C, Johnson KJ.

Pediatrics. 2013 May;131(5):846-54. doi: 10.1542/peds.2012-2520. Epub 2013 Apr 15.

15.

Host risk factors, ultraviolet index of residence, and incident malignant melanoma in situ among US women and men.

Walls AC, Han J, Li T, Qureshi AA.

Am J Epidemiol. 2013 May 1;177(9):997-1005. doi: 10.1093/aje/kws335. Epub 2013 Apr 11.

16.

Screening and prevention measures for melanoma: is there a survival advantage?

Curiel-Lewandrowski C, Chen SC, Swetter SM; Melanoma Prevention Working Group-Pigmented Skin Lesion Sub-Committee.

Curr Oncol Rep. 2012 Oct;14(5):458-67. Review.

17.

A questionnaire to measure melanoma risk, knowledge and protective behaviour: assessing content validity in a convenience sample of Scots and Australians.

Gillespie HS, Watson T, Emery JD, Lee AJ, Murchie P.

BMC Med Res Methodol. 2011 Aug 25;11:123. doi: 10.1186/1471-2288-11-123.

18.

Cutaneous melanoma in situ: translational evidence from a large population-based study.

Mocellin S, Nitti D.

Oncologist. 2011;16(6):896-903. doi: 10.1634/theoncologist.2010-0340. Epub 2011 May 31.

19.

Nevi, family history, and fair skin increase the risk of second primary melanoma.

Siskind V, Hughes MC, Palmer JM, Symmons JM, Aitken JF, Martin NG, Hayward NK, Whiteman DC.

J Invest Dermatol. 2011 Feb;131(2):461-7. doi: 10.1038/jid.2010.298. Epub 2010 Oct 14.

20.

The determination of melanoma stage at diagnosis.

Lee JA.

Dermatol Res Pract. 2010;2010:839829. doi: 10.1155/2010/839829. Epub 2010 Jun 28.

Items per page

Supplemental Content

Write to the Help Desk